Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use
Abstract
Radiopharmaceutical compositions including .sup.117m Sn labeled stannic (Sn.sup.4+) chelates are provided. The chelates are preferably polyhydroxycarboxylate, such as oxalates, tartrates, citrates, malonates, gluconates, glucoheptonates and the like. Methods of making .sup.117m Sn-labeled (Sn.sup.4+) polyhydroxycarboxylic chelates are also provided. The foregoing pharmaceutical compositions can be used in methods of preparing bone for scintigraphical analysis, for radiopharmaceutical skeletal imaging, treatment of pain resulting from metastatic bone involvement, treatment of primary bone cancer, treatment of cancer resulting from metastatic spread to bone from other primary cancers, treatment of pain resulting from rheumatoid arthritis, treatment of bone/joint disorders and to monitor radioactively the skeletal system.
- Inventors:
-
- Setauket, NY
- Middle Island, NY
- Issue Date:
- Research Org.:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- OSTI Identifier:
- 873731
- Patent Number(s):
- 6231832
- Assignee:
- Brookhaven Science Associates (Upton, NY)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- DOE Contract Number:
- AC02-98CH10886
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- radiopharmaceutical; stannic; sn-117m; chelate; compositions; methods; including; 117m; labeled; chelates; provided; preferably; polyhydroxycarboxylate; oxalates; tartrates; citrates; malonates; gluconates; glucoheptonates; sn-labeled; polyhydroxycarboxylic; foregoing; pharmaceutical; preparing; bone; scintigraphical; analysis; skeletal; imaging; treatment; pain; resulting; metastatic; involvement; primary; cancer; spread; cancers; rheumatoid; arthritis; joint; disorders; monitor; radioactively; compositions including; pharmaceutical compositions; radiopharmaceutical composition; pharmaceutical composition; rheumatoid arthritis; sn-117m chelate; bone cancer; /424/999/
Citation Formats
Srivastava, Suresh C, and Meinken, George E. Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use. United States: N. p., 2001.
Web.
Srivastava, Suresh C, & Meinken, George E. Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use. United States.
Srivastava, Suresh C, and Meinken, George E. Mon .
"Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use". United States. https://www.osti.gov/servlets/purl/873731.
@article{osti_873731,
title = {Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use},
author = {Srivastava, Suresh C and Meinken, George E},
abstractNote = {Radiopharmaceutical compositions including .sup.117m Sn labeled stannic (Sn.sup.4+) chelates are provided. The chelates are preferably polyhydroxycarboxylate, such as oxalates, tartrates, citrates, malonates, gluconates, glucoheptonates and the like. Methods of making .sup.117m Sn-labeled (Sn.sup.4+) polyhydroxycarboxylic chelates are also provided. The foregoing pharmaceutical compositions can be used in methods of preparing bone for scintigraphical analysis, for radiopharmaceutical skeletal imaging, treatment of pain resulting from metastatic bone involvement, treatment of primary bone cancer, treatment of cancer resulting from metastatic spread to bone from other primary cancers, treatment of pain resulting from rheumatoid arthritis, treatment of bone/joint disorders and to monitor radioactively the skeletal system.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Mon Jan 01 00:00:00 EST 2001},
month = {Mon Jan 01 00:00:00 EST 2001}
}
Works referenced in this record:
The development and in-vivo behavior of tin containing radiopharmaceuticals—II. Autoradiographic and scintigraphic studies in normal animals and in animal models of bone disease
journal, January 1985
- Oster, Z. H.; Som, P.; Srivastava, S. C.
- International Journal of Nuclear Medicine and Biology, Vol. 12, Issue 3
Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.
journal, January 1993
- Atkins, H. L.; Mausner, L. F.; Srivastava, S. C.
- Radiology, Vol. 186, Issue 1
Tin-117m: Production, chemistry and evaluation as a bone-scanning agent
journal, June 1973
- Yano, Yukio; Chu, Patricia; Anger, Hal O.
- The International Journal of Applied Radiation and Isotopes, Vol. 24, Issue 6
The development and in-vivo behavior of tin containing radiopharmaceuticals—I. Chemistry, preparation, and biodistribution in small animals
journal, January 1985
- Srivastava, S. C.; Meinken, G. E.; Richards, P.
- International Journal of Nuclear Medicine and Biology, Vol. 12, Issue 3